PDCD1 and hepatocellular carcinoma: The immune pathways are regulated not only by the PD-1/PD-L1 axis but by other ones, such as CTLA-4/B7 and TIGIT/CD112, which can contribute to the pathogenesis of MASLD and to the transitioning of HCC.